A Review of Anti-inflammatory Terpenoids from the Incense Gum Resins Frankincense and Myrrh
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) Shi, F.; Zhao, J.-H.; Liu, Y.; Wang, Z.; Zhang, Y.-T.; Feng, N.-P. Preparation and characterization of solid lipid nanoperticles loaded with frankincense and myrrh oil. Int. J. Nanomed. 7, 2033-2043 (2012).
2) Shen, T.; Lou, H.-X. Bioactive constituents of Myrrh and Frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine. Chem. Biodiv. 5, 540-552 (2008).
3) Sellar, W.; Watt, M. Frankincense & Myrrh: through the ages and a complete guide to their use in herbalism and aromatherapy today. The C.W. Daniel Co., Ltd., Cambridge, pp. 1-21 (1996).
4) Shanghai Scientific and Technologic Press, Dictionary of Chinese Traditional Medicines. Shogakkan, Tokyo, pp. 2012-2014 (1985).
5) PDR for Herbal Medicines Fourth Edition (Gruenwald, J.; Brendler, T.; Jaenicke, C. ed.), Thomson Helthcare Inc., Montvale, NJ, pp. 337-340 (2007).
6) Moussaieff, A.; Mechoulam, R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J. Pharm. Pharmcol. 61, 1281-1293 (2009).
7) Mertens, M.; Buettner, A.; Kirchhoff, E. The volatile constituents of frankincense – a review. Flavour Fragr. J. 24, 279-300 (2009).
8) Niebler, J.; Buettner, A. Identification of odorants in frankincense (Boswellia sacra Flueck.) by aroma extract dilution analysis and two-dimensional gas chromatography-mass spectrometry/olfactometry. Phytochemistry 109, 66-75 (2015).
9) Verhoff, M.; Seitz, S.; Paul, M.; Noha, S.M.; Jauch, J.; Schuster, D.; Werz, O. Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy Frankincense as inhibitors of microsomal prostaglandin E2 synthase-1. J. Nat. Prod. 77, 1445-1451 (2014).
10) Safayhi, H.; Boden, S.E.; Schweizer, S.; Ammon, H.P. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med. 66, 110-113 (2000).
11) Fn, A.Y.; Lao, L.; Zhang, R.X.; Zhou, A.N.; Wang, L.B.; Moudgil, K.D.; Lee, D.Y.W.; Ma, Z.Z.; Berman, B.M. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. J. Ethnopharmacol. 101, 104-109 (2005).
12) Banno, N.; Akihisa, T.; Yasukawa, K.; Tokuda, H.; Tabata, K.; Nakamura, Y.; Nishimura, R.; Kimura, Y.; Suzuki, T. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J. Ethnopharmacol. 107, 249-253 (2006).
13) Yoshikawa, M.; Morikawa, T.; Oominami, H.; Matsuda, H. Absolute stereostructures of olibanumols A, B, C, H, I, and J from Olibanum, gum-resin of Boswellia carterii, and inhibitors of nitric oxide production in lipopolysaccharide-activated mouse peritoneal macrophages. Chem. Pharm. Bull. 57, 957-964 (2009).
14) Li, X.-J.; Yang, Y.-J.; Li, Y.-S.; Zhang, W.K.; Tang, H.-B. α-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2. J. Ethnopharmacol. 179, 22-26 (2016).
15) Pollastro, F.; Golin, S.; Chianese, G.; Putra, M.Y.; Moriello, A.S.; De Petrocellis, L.; García, V.; Munoz, E.; Tagliatela-Scafati, O.; Appendino, G. Neuroactive and anti-inflammatory Frankincense cembranes: a structure-activity study. J. Nat. Prod. 79, 1762-1768 (2016).
16) Mothana, R.A. Anti-inflammatory, anticiceptive and antioxidant activities of the endemic Soqotraen Boswellia elongate Balf. and Jatropha unicostata Balf. F. in different experimental models. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 49, 2594-2599 (2011).
18) Büchele, B.; Zugmaier, W.; Estrada, A.; Genze, F.; Syrovetes, T.; Paetz, C.; Schneider, B.; Simmet, T. Characterization of 3α-acetyl-11-keto-α-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo. Planta Med. 72, 1285-1289 (2006).
19) Akihisa, T.; Tabata, K.; Banno, N.; Tokuda, H.; Nishihara, R.; Nakamura, Y.; Kimura, Y.; Yasukawa, K.; Suzuki, T. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Biol. Pharm. Bull. 29, 1976-1979 (2006).
20) Singh, S.; Khajuria, A.; Taneja, S.C.; Johri, R.K. Singh, J.; Qazi, G.N. Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 15, 400-407 (2008).
21) Eichhorn, T.; Greten, H.J.; Efferth, T. Molecular determinations of the response of tumor cells to boswellic acids. Pharmaceuticals 4, 1171-1182 (2011).
22) Hasson, S.S.; Al-Balushi, M.S.; Sallam, T.A.; Idris, M.A.; Habbal, O.; Al-Jabri, A.A. In vitro antibacterial activity of three medicinal plants – Boswellia (Luban) species. Asian Pac. J. Trop. Biomed. 1 Suppl., S178-S182 (2011).
23) Kokkiripati, P.K.; Bhakshu, L.M.; Marri, S.; Padmasree, K.; Row, A.T.; Raghavendra, A.S.; Tetali, S.D. Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation. J. Ethnopharmacol. 137, 893-901 (2011).
24) Pan, Y.-N.; Liang, X.-X.; Niu, L.-Y.; Wang, Y.-N.; Tong, X.; Hua, H.-M.; Zheng, J.; Meng, D.-Y.; Liu, X.-Q. Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of frankincense and its processed products. J. Ethnopharmacol. 172, 118-123 (2015).
25) Hamm, S.; Bleton, J.; Connan, J.; Tchapla, A. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry 66, 1499-1514 (2005).
26) Morikawa, T.; Oominami, H.; Matsuda, H.; Yoshikawa, M. New terpenoids, olibanumols D-G, from traditional Egyptian medicine olibanum, the gum-resin of Boswellia carterii. J. Nat. Med. 65, 129-134 (2011).
27) Morikawa, T.; Oominami, H.; Matsuda, H.; Yoshikawa, M. Four new ursane-type titerpenes, olibanumols K, L, M, and N, from traditional Egyptian medicine Olibanum, the gum-resin of Boswellia carterii. Chem. Pharm. Bull. 58, 1541-1544 (2010).
28) Du, Z.; Liu, Z.; Ning, Z.; Liu, Y.; Song, Z.; Wang, C.; Lu, A. Prospects of boswellic acid as potential pharmaceutics. Planta Med. 81, 259-271 (2015).
29) Shanghai Scientific and Technologic Press, Dictionary of Chinese Traditional Medicines. Shogakkan, Tokyo, pp. 2532-2534 (1985).
30) PDR for Herbal Medicines Fourth Edition (Gruenwald, J.; Brendler, T.; Jaenicke, C. ed.), Thomson Helthcare Inc., Montvale, NJ, pp. 595-596 (2007).
31) Xu, J.; Guo, Y.; Li, Y.; Zhao, P.; Liu, C.; Ma, Y.; Gao, J.; Hou, W.; Zhang, T. Sesquiterpenoids from the resinous exudates of Commiphora myrrha and their neuroprotective effects. Planta Med. 77, 2023-2028 (2011).
32) Kimura, I.; Yoshikawa, M.; Kobayashi, S.; Sugihara, Y.; Suzuki, M.; Oominami, H.; Murakami, T.; Matsuda, H.; Doiphode, V.V. New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice. Bioorg. Med. Chem. Lett. 11, 985-989 (2001).
33) Matsuda, H.; Morikawa, T.; Ando, S.; Oominami, H.; Murakami, T.; Kimura, I.; Yoshikawa, M. Absolute stereostructures of polypodane- and octanordammarane-type triterpenes with nitric oxide production inhibitory activity from guggul-gum resins. Bioorg. Med. Chem. 12, 3037-3046 (2004).
34) Matsuda, H.; Morikawa, T.; Ando, S.; Oominami, H.; Murakami, T.; Kimura, I.; Yoshikawa, M. Absolute stereostructures of polypodane-type triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resin (the Resin of Balsamodendron mukul). Chem. Pharm. Bull. 52, 1200-1203 (2004).
35) Habtemariam, S. Cytotoxic and cytostatic activity of erlangerins from Commiphora erlangeriana. Toxicon. 41, 723-727 (2003).
36) Shoemaker, M.; Hamilton, B.; Dairkee, S.H.; Cohen, I.; Campbell M. J. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytocher. Res. 19, 649-651 (2005).
37) Shen, T.; Wan, W.; Yuan, H.; Kong, F.; Guo, H.; Fan, P.; Lou, H. Secondary metabolites from Commiphora opobalsamum and their antiproliferative effect on human prostate cancer cells. Phytochemistry 68, 1331-1337 (2007).
38) Dolara, P.; Luceri, C.; Ghelardini, C.; Monserrat, C.; Aiolli, S.; Luceri, F.; Lodovici, M.; Menichetti, S.; Romanelli, M.N. Analgesic effects of myrrh. Nature 379, 29 (1996).
39) Meselhy, M.R. Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents. Phytochemisrty 62, 213-218 (2003).
40) Francis, J.A.; Raja, S.N.; Nair, M.G. Bioactive terpenoids and guggulusteroids from Commiphora mukul gum resin of potential anti-inflammatory interest. Chem. Biodiv. 1, 1842-1853 (2004).
41) Saeed, M.A.; Sabir, A.W. Antibacterial activities of some constituents from oleo-gum-resin of Commiphora mukul. Fitotherapia 75, 204-208 (2004).
42) Dolara, P.; Corte, B.; Ghelardini, C.; Pugliese, A.M.; Cerbai, E. Menichetti, S.; Lo Nostro, A. Local anaesthetic, antibacterial, and antifungal properties of sesquiterpenes from myrrh. Planta Med. 66, 356-358 (2000).
43) Meeker, H.G.; Linke, H.A. The antibacterial action of eugenol, thyme oil, and related essential oils used in dentistry. Compend. Contin. Educ. Dent. 9, 32-35 (1988).
44) Chander, R.; Khanna, A.K.; Kapoor, N.K. Lipid lowering activity of guggulsterone from Commiphora mukul in hyperlipaemic rats. Phytother. Res. 10, 508-511 (1996).
45) Beg, M.; Singhal, K.C.; Afzaal, S.A Study of effect of guggulsterone on hyperlipidemia of secondary glomeruloparthy. Indian J. Physiol. Pharmacol. 40, 237-240 (1996).
46) Xu, J.; Guo, Y.; Zhao, P.; Xie, C.; Jin, D.; Hou, W.; Zhang, T. Neuroprotective cadinane sesquiterpenes from the resinous exudates of Commiphora myrrha. Fitotherapia 82, 1198-1201 (2011).
47) Zhu, N.; Kikuzaki, H.; Sheng, S.; Sang, S.; Rafi, M.M.; Wang, M.; Nakatani, N.; DiPaola, R.S.; Rosen, R.T.; Ho, C.T. Furanosesquiterpenoids of Commiphora myrrha. J. Nat. Prod. 64, 1460-1462 (2001).
48) Zhu, N.; Sheng, S.; Sang, S.; Rosen, R.T.; Ho, C.T. Isolation and characterization of several aromatic sesquiterpenes from Commiphora myrrha. Flav. Fragr. J. 18, 282-285 (2003).
49) Shen, T.; Wan, W.Z.; Wang, X.N.; Yuan, H.Q.; Ji, M.; Lou, H.X. A triterpenoid and sesquiterpenoids from the resinous exudates of Commiphora myrrha. Helv. Chim. Acta 92, 645-652 (2009).
50) Su, S.L.; Duan, J.A.; Tang, Y.P.; Zhang, X.; Yu, L.; Jiang, F.R.; Zhou, W.; Luo, D.; Ding, A.W. Isolation and biological activities of neomyrrhanol and other terpenes from the resin of Commiphora myrrha. Plant Med. 75, 351-355 (2009).
51) Ubillas, R.P.; Mendez, C.D.; Jolad, S.D.; Luo, J.; King, S.R.; Carlson, T.J.; Fort, D.M. Anti-hyperglycemic furanosesquiterpenes from Commiphora myrrha. Plant Med. 65, 778-779 (1999).
52) Patil, V.D.; Nayak, U.R.; Dev, S. Chemistry of Ayurvedic crude drugs-I: Guggulu (resin from Commiphora mukul)-1: Steroidal constituents. Therahedron 28, 2341-2352 (1972).
53) Patil, V.D.; Nayak, U.R.; Dev, S. Chemistry of Ayurvedic crude drugs-II: Guggulu (resin from Commiphora mukul) -2: Diterpenoid constituents. Therahedron 29, 341-348 (1973).
54) Patil, V.D.; Nayak, U.R.; Dev, S. Chemistry of Ayurvedic crude drugs-III: Guggulu (resin from Commiphora mukul) -3: long-chain aliphatic tetrols, a new class of naturally occurring lipids. Therahedron 29, 1595-1598 (1973).
55) Prasad, R.S.; Dev, S. Chemistry of Ayurvedic crude drugs-IV: Guggulu (resin from Commiphora mukul) -4: absolute stereochemistyy of mukulol. Therahedron, 32, 1437-1441 (1976).
56) Bajaj, A.G.; Dev, S. Chemistry of Ayurvedic crude drugs-V: Guggulu (resin from Commiphora mukul)-5: some new steroidal components and stereochemistry of guggulsterol-I at C-20 and C-22. Therahedron 38, 2949-2954 (1982).
57) Kumar, V.; Dev, S. Chemistry of Ayurvedic Crude Drugs-VII: Guggulu (resin from Commiphora mukul)-6: absolute stereochemistry of guggultetrols. Therahedron 43, 5933-5948 (1987).
58) Swaminathan, S.; Bakshi, R.K.; Dev, S. Higherisoprenoids-XIX: Guggulsterones to dexamethasone. Tetrahedron 43, 3827-3838 (1987).
59) Fatope, M.O.; Al-Burtomani, S.K.S.; Ochei, J.O.; Abdulnour, A.O.; Al-Kindy, S.M.Z.; Takeda, Y. Muscanone: A 3-O-1”,8”,14”-trimethylhexadecanylnaringenin from Commiphora wightii. Phytochemistry 62, 1251-1255 (2003).
60) Zhu, N.; Rafi, M.M.; DiPaola, R.S.; Xin, J.; Chin, C.K.; Badmaev, V.; Ghai, G.; Rosen, R.T.; Ho, C.T. Bioactive constituents from gum guggul Commiphora wightii. Phytochemistry 56, 723-727 (2001).
61) Fourie, T.G.; Snyckers, F.O.A Pentacyclic triterpene with anti-inflammatory and analgesic activity from the roots of Commiphora merkeri. J. Nat. Prod., 52, 1129-1131 (1989).
62) Provan, G.J.; Waterman, P.G. Chemistry of the Burseraceae. Part 10. Major triterpenes from the resins of Commiphora incisa and C. kua and their potential chemotaxonomic significance. Phytochemistry 27, 3841-3843 (1988).
63) Dekebo, A.; Dagne, E.; Hansen, L.K.; Gautun, O.R.; Aasen, A.J. Two octanordammarane triterpenes from Commiphora kua. Phytochemistry 59, 399-403 (2002).
64) Brieskorn, C.H.; Noble, P. Three new furanogermacrenes from myrrh. Tetrahedron Lett. 21, 1511-1514 (1980).
65) Dekebo, A.; Lang, M.; Polborn, K.; Dagne, E.; Steglich, W. Four Lignans from Commiphora erlangeriana. J. Nat. Prod. 65, 1252-1257 (2002).
66) Waterman, P.G.; Ampofo, S. Chemistry of the Burseraceae. Part 2. Dammarane triterpenes from the stem bark of Commiphora dalzielii. Phytochemistry 24, 2925-2928 (1985).
67) Shen, T.; Wan, W.Z.; Wang, X.N.; Sun, L.M.; Yuan, H.Q.; Wang, X.L.; Ji, M.; Lou, H.X. Sesquiterpenoids from the resinous exudates of Commiphora opobalsamum (Burseraceae). Helv. Chim. Acta 91, 881-887 (2008).
68) Shen, T.; Yuan, H.Q.; Wan, W.Z.; Wang, X.L.; Wang, X.L.; Ji, M.; Luo, H.X. Cycloartane-type triterpenoids from the resinous exudates of Commiphora opobalsamum. J. Nat. Prod. 71, 81-86 (2008).
69) Zhao, N.; Yang, G.-C.; Li, D.-H.; Li, X.-L.; Li, Z.-L.; Bai, J.; Liu, X.-Q.; Hua, H.-M. Two New Sesquiterpenes from Myrrh. Helv. Chim. Acta 98, 1332-1336 (2015).
70) Kontush, A.; Chapman, M.J. Functionally defective high-density lipoprotein: a review theraputic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58, 342-374 (2006).
71) Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
72) MacMicking, J.; Xie, Q.W.; Nathan, C. Nitric oxide and macrophage function. Ann. Rev. Immunol. 15, 323-350 (1997).
73) Rao, Y.K.; Fang, S.H.; Tzeng, Y.M. Anti-inflammatory activities of flavonoids isolated from Caesalpinia pulcherrima. J. Ethnopharmacol. 100, 249-253 (2005).